Vienna, Austria

Carsten Peters

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carsten Peters. Retrieved from https://idiyas.com/inventor/carsten-peters-e3sw5yyq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carsten Peters: Innovator in Peptidomimetics

Introduction

Carsten Peters is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biochemistry, particularly in the development of peptidomimetics. His work focuses on creating analogues of amino acid sequences that have potential applications in medical research.

Latest Patents

Carsten Peters holds a patent for "KAPREKY peptidomimetics and analogues thereof." This patent involves analogues of the amino acid sequence KAPREKY and their use in screening for compounds that interact with FcεRIα. This innovation has the potential to advance research in immunology and therapeutic development.

Career Highlights

Carsten Peters is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects.

Collaborations

Throughout his career, Carsten has worked alongside notable colleagues such as Klaus Weigand and Christoph Buenemann. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.

Conclusion

Carsten Peters is a distinguished inventor whose work in peptidomimetics is paving the way for new discoveries in biochemistry and medicine. His contributions are invaluable to the scientific community and hold promise for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…